TAM
Tocqueville Asset Management’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.5K | Sell |
63,500
-1,500
| -2% | -$1.48K | ﹤0.01% | 525 |
|
|
2025
Q1 | $93.6K | Sell |
65,000
-5,000
| -7% | -$7.2K | ﹤0.01% | 504 |
|
|
2024
Q4 | $154K | Sell |
70,000
-2,500
| -3% | -$5.5K | ﹤0.01% | 527 |
|
|
2024
Q3 | $120K | Sell |
72,500
-5,000
| -6% | -$8.25K | ﹤0.01% | 516 |
|
|
2024
Q2 | $172K | Buy |
77,500
+37,750
| +95% | +$83.8K | ﹤0.01% | 507 |
|
|
2024
Q1 | $107K | Buy |
+39,750
| New | +$107K | ﹤0.01% | 523 |
|
|
2020
Q3 | – | Sell |
-5,500
| Closed | -$282K | – | 661 |
|
|
2020
Q2 | $282K | Buy |
+5,500
| New | +$282K | 0.01% | 574 |
|
|
2020
Q1 | – | Sell |
-5,500
| Closed | -$328K | – | 657 |
|
|
2019
Q4 | $328K | Buy |
+5,500
| New | +$328K | ﹤0.01% | 634 |
|
|
2018
Q2 | – | Sell |
-2,975
| Closed | -$215K | – | 832 |
|
|
2018
Q1 | $215K | Buy |
+2,975
| New | +$215K | ﹤0.01% | 772 |
|